Novo Integrated Sciences Gross Profit 2012-2024 | NVOS

Novo Integrated Sciences gross profit from 2012 to 2024. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
Novo Integrated Sciences Annual Gross Profit
(Millions of US $)
2023 $5
2022 $5
2021 $4
2020 $3
2019 $4
2018 $3
2017 $3
2016 $
2016 $3
2015 $
2014 $
2013 $
2012 $
2012 $
2011 $
2011 $
Novo Integrated Sciences Quarterly Gross Profit
(Millions of US $)
2024-02-29 $1
2023-11-30 $2
2023-08-31 $1
2023-05-31 $1
2023-02-28 $1
2022-11-30 $2
2022-08-31 $-0
2022-05-31 $2
2022-02-28 $1
2021-11-30 $1
2021-08-31 $1
2021-05-31 $1
2021-02-28 $1
2020-11-30 $1
2020-08-31 $1
2020-05-31 $0
2020-02-29 $1
2019-11-30 $1
2019-08-31 $1
2019-05-31 $1
2019-02-28 $1
2018-11-30 $1
2018-08-31 $1
2018-05-31 $1
2018-02-28 $1
2017-11-30 $1
2017-08-31 $1
2017-05-31 $1
2017-03-31
2017-02-28 $1
2016-12-31
2016-11-30 $1
2016-09-30
2016-06-30
2016-05-31 $1
2016-03-31
2015-12-31
2015-09-30
2015-06-30
2015-03-31
2014-12-31
2014-09-30
2014-06-30
2014-03-31
2013-12-31
2013-09-30
2013-06-30
2013-03-31
2012-12-31
2012-09-30
2012-08-31
2012-06-30
2012-03-31
2012-02-29
2011-12-31
2011-11-30
2011-09-30
2011-08-31
2011-06-30
2011-05-31
2011-03-31
2011-02-28
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.009B $0.013B
Novo Integrated Sciences Inc. is a provider of multi-dimensional primary healthcare services and products principally in Canada and the U.S. It deliver or intend to deliver, multidisciplinary primary health care related services and products through the integration of medical technology, advanced therapeutics and rehabilitative science, through its subsidiaries. Novo Integrated Sciences Inc. is based in Bellevue, Washington.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $16.733B 10.12
Quest Diagnostics (DGX) United States $15.759B 16.29
DaVita (DVA) United States $11.818B 14.68
Encompass Health (EHC) United States $8.593B 22.00
Chemed (CHE) United States $8.450B 26.19
Elanco Animal Health (ELAN) United States $8.367B 21.70
Option Care Health (OPCH) United States $5.046B 19.10
RadNet (RDNT) United States $4.290B 89.34
Amedisys (AMED) United States $3.162B 22.40
LifeStance Health (LFST) United States $2.221B 0.00
Astrana Health (ASTH) United States $2.135B 28.86
Addus HomeCare (ADUS) United States $1.805B 25.82
U.S Physical Therapy (USPH) United States $1.554B 41.57
Pennant (PNTG) United States $0.695B 36.71
Aveanna Healthcare Holdings (AVAH) United States $0.543B 0.00
Atai Life Sciences (ATAI) Germany $0.280B 0.00
Daxor (DXR) United States $0.045B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.028B 0.00
ATI Physical Therapy (ATIP) United States $0.022B 0.00
Psychemedics (PMD) United States $0.015B 0.00
Ontrak (OTRK) United States $0.013B 0.00
IMAC Holdings (BACK) United States $0.004B 0.00